views
![Arginase Deficiency Market Size, Share, Growth Analysis](https://s3.us-west-2.amazonaws.com/timessquarereporter.com/upload/media/posts/2024-04/09/arginase-deficiency-market-size-share-growth-analysis_1712651891-b.jpg)
"The comprehensive Arginase Deficiency Market report broadly encompasses absolute and distinct analysis of the market drivers and restraints, major market players involved in the Arginase Deficiency Market industry, exhaustive analysis of the market segmentation, and competitive analysis of the key players. All the data and information involved in the report is taken from incredibly trustworthy sources such as websites, annual reports of the companies, white papers, journals, newspapers, and mergers. A number of estimations and calculations have been executed in the world class Arginase Deficiency Market research report by assuming definite base year and the historic year.
By synchronizing with project managers, the team provide the clients on every strategic aspect including product development, key areas of development, application modelling, use of technologies, the acquisition strategies, exploring niche growth opportunities and new markets. It includes the detailed profiles for the Arginase Deficiency Market’s major manufacturers and importers who are influencing the market. To achieve success in the competition of global market place, going for the worldwide Arginase Deficiency Market research report is the key. The report takes into account all the opportunities, challenges, drivers, market structures, and competitive landscape for the clients.
Data Bridge Market Research analyses a growth rate in the arginase deficiency market in the forecast period 2023-2030. The expected CAGR arginase deficiency market is tend to be around 4% in the mentioned forecast period. The market was valued at USD 100 million in 2022, and it would grow upto USD 136.8 million by 2030.
Explore Further Details about This Research Arginase Deficiency Market Report https://www.databridgemarketresearch.com/reports/global-arginase-deficiency-market
Arginase Deficiency Market Scope and Segmentation
REPORT METRIC |
DETAILS |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015 - 2020) |
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
Segments Covered |
Diagnosis (Genetic Testing, New-born Screening Others), Treatment (Nitrogen-Binding Adjunctive, Nitrogen Scavenger Drugs, Anti-Seizure Drugs, Intravenous (IV) Fluids, Others), Drug Type (Branded, Generic), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
Horizon Therapeutics plc (Dublin), Bausch Health Companies Inc. (Canada), Sigmapharm Laboratories, LLC (U.S.), Par Pharmaceutical. (U.S.), Aeglea BioTherapeutics (Austin) |
Market Opportunities |
|
Market Definition
Arginase deficiency is a type of inherited metabolic disorder that is characterized by the partial and complete lack of arginase enzyme in the red blood cells and liver. The lack of arginase enzyme causes excessive accumulation of nitrogen in the form of arginine and ammonia in the cerebrospinal fluid and blood. If the deficiency is not treated on time properly, it may lead to spasticity, short stature, seizures, and intellectual disability may occurs. The accumulation of ammonia in the blood causes the symptoms of NAGS deficiency. In the most extreme cases, the symptoms of this deficiency occur within 24-72 hours after birth.
Arginase Deficiency Market Dynamics
Drivers
- Growing Adoption of Injectable Route of Administration
Injection arginase deficiency drugs are used in cases where oral medications are either unavailable or unsuitable for specific patients such as infants, children, and those suffering from severe kidney disease, and other conditions that prevent normal pill consumption. In addition to this, it also aids in improving patient adherence to their prescribed medication, further improving their health condition.
Opportunities
- Increasing Demand For Hospitals
Drug stores and hospitals consider to be the major application segments of arginase deficiency drugs. In 2015, the hospital segment dominated the global market with a more than 80% revenue share. The segment is estimated to witness major growth due to increasing healthcare expenditure and a growing number of patients suffering from life-threatening diseases such as cancer, who require intravenous (IV) nutrition for treatment.
- Varied Options For Diagnostic Tests
A diagnosis of NAGS deficiency can be done through a detailed patient or family history, identification of specialized findings, and a variety of particular tests. Blood tests may show excessive amounts of ammonia in the blood, which is the primary finding of urea cycles disorders. Though, increased levels of ammonia in the blood may describe other disorders such as the congenital lactic acidosis, organic acidemias, and fatty acid oxidation disorders. Urea cycles disorders can be distinguished from these disorders through the examination of urine for increased levels of or abnormal organic acids.
What insights readers can gather from the Arginase Deficiency Market report?
- Learn the behavior pattern of every Arginase Deficiency Market -product launches, expansions, collaborations and acquisitions in the market currently.
- Examine and study the progress outlook of the global Arginase Deficiency Market landscape, which includes, revenue, production & consumption and historical & forecast.
- Understand important drivers, restraints, opportunities and trends (DROT Analysis).
- Important trends, such as carbon footprint, R&D developments, prototype technologies, and globalization
Why choose Data Bridge Market Research?
- Modern technologies, such as artificial intelligence, to provide updated industry growth.
- DBMR team provides clients with the top notch Arginase Deficiency Market research report.
- Interaction with research scientists and development heads to understand the nature of the Arginase Deficiency Market more precisely.
- 24/7 availability of services.
- Data collection from implementation vendors, service providers, and raw material suppliers to provide a clear perspective with Forecast period.
DBMR team uses very fair means to gather information that is scrutinized at every stage while structuring an influential Arginase Deficiency Market size
Browse Related Reports:
Epilepsy Monitoring Devices Market Size, Industry Share Forecast
Cyclohexylbenzene Market Size, Share, Growth | Opportunities,
Dimethyldichlorosilane Market Size, Share Analysis Report
Antifreeze/Coolant Market Size, Share, Growth Analysis
Immunoturbidimetry Reagents Market Size, Share, Growth
Drilling Fluid Additives Market Demand,Size ,Share, Industry
Olivopontocerebellar Atrophy (OPCA) Market Size, Analysis and Forecast
Transmission Fluids Market Size, Share, Trends & Forecast
Automatic Slack Adjuster Market Size And Share Analysis Report,
Cake Pops Market by Size, Share, Forecast, & Trends
Conductive Textiles Market Size Report- Industry Growth Analysis
Crop Protection Chemicals Market Size, Industry Share Forecast
Cyclic Neutropenia Treatment Market Size, Share, Growth | Opportunities,
Diamond-Blackfan Anemia Treatment Market Size, Share Analysis Report
Aluminum Rolled Products Market Size, Share, Growth Analysis
About Data Bridge Market Research:
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]
"
![disclaimer](https://www.timessquarereporter.com/disclaimer-timessquarereporter.jpg)
Comments
0 comment